UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer

Current opinion in oncology, 2024-01, Vol.36 (1), p.29-34

Huber, Rudolf M.

2024

Volltextzugriff (PDF)

Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression

PloS one, 2016-05, Vol.11 (5), p.e0156268-e0156268

2016

Volltextzugriff (PDF)

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication

PloS one, 2016-10, Vol.11 (10), p.e0163408

2016

Volltextzugriff (PDF)

Early detection of lung cancer - current status and implementation scenarios

Pneumologie (Stuttgart, Germany), 2023-12, Vol.77 (12), p.1016

Huber, Rudolf M

2023

Volltextzugriff (PDF)

Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

Journal of thoracic oncology, 2022-01, Vol.17 (1), p.56-66

2022

Volltextzugriff (PDF)

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

The lancet oncology, 2015-03, Vol.16 (3), p.257-265

2015

Volltextzugriff (PDF)

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

European respiratory review, 2019-06, Vol.28 (152), p.190024

2019

Volltextzugriff (PDF)

Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Drugs (New York, N.Y.), 2021-01, Vol.81 (1), p.87-100

2021

Volltextzugriff (PDF)

Reference values of impulse oscillometric lung function indices in adults of advanced age

PloS one, 2013-05, Vol.8 (5), p.e63366-e63366

2013

Volltextzugriff (PDF)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort

PloS one, 2017-05, Vol.12 (5), p.e0177501-e0177501

2017

Volltextzugriff (PDF)

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.194-207

2017

Volltextzugriff (PDF)

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Journal of thoracic oncology, 2015-01, Vol.10 (1), p.156-163

2015

Volltextzugriff (PDF)

Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.404-415

2020

Volltextzugriff (PDF)

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2490-2498

2017

Volltextzugriff (PDF)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

Respiratory research, 2018-06, Vol.19 (1), p.110-110, Article 110

2018

Volltextzugriff (PDF)

Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Drugs (New York, N.Y.), 2021-06, Vol.81 (9), p.1131-1131

2021

Volltextzugriff (PDF)

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2693-2701

2018

Volltextzugriff (PDF)

Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells

Anticancer research, 2020-03, Vol.40 (3), p.1451-1458

2020

Volltextzugriff (PDF)

Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice

Journal of cancer research and clinical oncology, 2023-10, Vol.149 (13), p.11679-11688

2023

Volltextzugriff (PDF)

Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations

Oncology research and treatment, 2020-06, Vol.43 (6), p.289-298

2020

Volltextzugriff (PDF)

New developments in locally advanced nonsmall cell lung cancer

European respiratory review, 2021-06, Vol.30 (160), p.200227

2021

Volltextzugriff (PDF)

Lung Cancer Screening in Persons Who Never Smoked Has to be Evaluated—A Response to Letter to the Editor

Journal of thoracic oncology, 2022-02, Vol.17 (2), p.e20-e21

2022

Volltextzugriff (PDF)

Lungenkrebsfrüherkennung – derzeitiger Stand und Implementationsszenarien

Pneumologie (Stuttgart, Germany), 2023-12, Vol.77 (12), p.1016-1026

Huber, Rudolf M.

2023

Volltextzugriff (PDF)

The revised GOLD 2017 COPD categorization in relation to comorbidities

Respiratory medicine, 2018-01, Vol.134, p.79-85

2018

Volltextzugriff (PDF)

1 – 25 von 1.722

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(643)
Mit Volltextzugriff
(1.615)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ebook Central Perpetual and DDA
(834)
eBooks on EBSCOhost
(743)
De Gruyter eBooks
(459)
Reference Global
(386)
Ingenta
(345)
MEDLINE
(339)
EZB Electronic Journals Library
(319)
Journals@OVID
(258)
IngentaConnect Journals
(141)
JSTOR All Journals
(140)
Standalone journals
(114)
Access via ScienceDirect (Elsevier)
(112)
SpringerLink
(103)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(86)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(64)
Access via Wiley Online Library
(61)
Wiley Online Library
(29)
Oxford Journals
(26)
Nomos eLibrary
(25)
Oxford Journals 2020 Medicine
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer

Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication

Early detection of lung cancer - current status and implementation scenarios

Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Reference values of impulse oscillometric lung function indices in adults of advanced age

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells

From the International Association for the Study of Lung Cancer Early Detection and Screening Committee: Terminology Issues in Screening and Early Detection of Lung Cancer—International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations

Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice

Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations

New developments in locally advanced nonsmall cell lung cancer

Lung Cancer Screening in Persons Who Never Smoked Has to be Evaluated—A Response to Letter to the Editor

Lungenkrebsfrüherkennung – derzeitiger Stand und Implementationsszenarien

The revised GOLD 2017 COPD categorization in relation to comorbidities

Suchergebnisse filtern